LPL Financial
CHRS icon

LPL Financial’s Coherus Oncology CHRS Stock Holding History

LPL Financial’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$67.4K Sell
48,167
-72,629
-60% -$119K ﹤0.01% 5987
2026
Q1 		$204K Buy
120,796
+22,255
+23% +$39.5K ﹤0.01% 5481
2025
Q4 		$140K Sell
98,541
-120,600
-55% -$176K ﹤0.01% 5541
2025
Q3 		$359K Buy
219,141
+17,302
+9% +$19.2K ﹤0.01% 4900
2025
Q2 		$148K Buy
201,839
+135,620
+205% +$117K ﹤0.01% 5178
2025
Q1 		$53.4K Buy
66,219
+1,454
+2% +$1.67K ﹤0.01% 5148
2024
Q4 		$89.4K Sell
64,765
-29,321
-31% -$32.9K ﹤0.01% 5013
2024
Q3 		$97.8K Sell
94,086
-24,400
-21% -$33.5K ﹤0.01% 4895
2024
Q2 		$205K Buy
118,486
+5,750
+5% +$11.6K ﹤0.01% 4552
2024
Q1 		$269K Buy
112,736
+57,702
+105% +$142K ﹤0.01% 4289
2023
Q4 		$183K Buy
+55,034
New +$147K ﹤0.01% 4415

Other funds holding CHRS

TGY2IT
Timothy G. Youngquist 2020 Irrevocable Trust Fort Myers, Florida $510M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return

LPL Financial's CHRS Position: Q2 2026 in Review

LPL Financial reduced its Coherus Oncology (CHRS) stake by 60% in Q2 2026, selling an estimated $119K and leaving 48,167 shares worth $67.4K. The position accounts for ﹤0.01% of the portfolio, ranked #5987.

LPL Financial first reported a position in CHRS in Q4 2023 and has held it in 11 quarters since. The position peaked at $359K in Q3 2025. 147 funds tracked by Wall St. Rank hold CHRS as of Q2 2026.

  • LPL Financial held 48,167 shares of Coherus Oncology worth $67.4K as of Q2 2026.
  • LPL Financial sold 72,629 Coherus Oncology shares in Q2 2026, an estimated $119K.
  • Coherus Oncology made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #5987 holding.
  • LPL Financial first reported a position in Coherus Oncology in Q4 2023 and has held it in 11 quarters since.
  • LPL Financial's Coherus Oncology position peaked at $359K in Q3 2025.
  • 147 funds tracked by Wall St. Rank held Coherus Oncology as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.